Compare EVEX & YDES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | EVEX | YDES |
|---|---|---|
| Founded | 2020 | 2013 |
| Country | United States | Taiwan |
| Employees | N/A | N/A |
| Industry | Aerospace | |
| Sector | Industrials | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.1B |
| IPO Year | N/A | N/A |
| Metric | EVEX | YDES |
|---|---|---|
| Price | $5.04 | $13.05 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $6.88 | N/A |
| AVG Volume (30 Days) | ★ 1.4M | 92.1K |
| Earning Date | 11-04-2025 | 09-30-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $510,360.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 45.76 |
| 52 Week Low | $2.83 | $5.30 |
| 52 Week High | $7.70 | $31.00 |
| Indicator | EVEX | YDES |
|---|---|---|
| Relative Strength Index (RSI) | 69.92 | N/A |
| Support Level | $3.65 | N/A |
| Resistance Level | $3.85 | N/A |
| Average True Range (ATR) | 0.28 | 0.00 |
| MACD | 0.14 | 0.00 |
| Stochastic Oscillator | 96.27 | 0.00 |
Eve Holding Inc is a provider of Urban Air Mobility solutions. The company's operating segments are; eVTOL that includes; the design and production of electric vertical take-off and landing vehicles (eVTOLs) including fixed wing and helicopter operators, as well as lessors that purchase and manage aircraft on behalf of operators; Service and Operations Solutions segment which includes a portfolio of maintenance and support services focused on its and third-party eVTOLs; and the UATM segment , a new Urban Air Traffic Management system designed to allow eVTOLs to operate safely and efficiently in dense urban airspace alongside conventional aircraft and drones.
YD Bio Ltd is a biopharmaceutical company focusing on blood-based cancer detection, the development of stem cell- and exosome-based therapeutics with the potential to transform the treatment of a wide spectrum of diseases with high unmet medical need and serving as a trusted supplier of clinical testing drugs for pharmaceutical companies. Stem cell therapy uses versatile cells to repair or regenerate damaged tissues, offering innovative treatments for injuries, degenerative diseases, and immune disorders with potential for personalized medicine and tissue engineering.